NCT04211545View on ClinicalTrials.gov

Relative Bioavailability and PPI Effects of CC-92480 Test and Reference Formulations in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

December 26, 2019

Study Completion Date

December 26, 2019

Conditions
Healthy Volunteer
Interventions
DRUG

Rabeprazole

Rabeprazole

DRUG

CC-92480

CC-92480

Trial Locations (1)

78744

PPD Phase 1 Clinic, Austin

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY